anti-osteoporotics (Roussel-Uclaf)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-osteoporotics (Roussel-Uclaf)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors agonists
TargetsEstrogen receptors
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis Pharma
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A